The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data.
about
The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbedExamination of Antibody Responses as a Measure of Exposure to Malaria in the Indigenous Batwa and Their Non-Indigenous Neighbors in Southwestern Uganda.Human immunity and the design of multi-component, single target vaccines.Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccinesDevelopment of a blocking enzyme-linked immunosorbent assay for detection of serum antibodies to O157 antigen of Escherichia coliPhase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adultsA novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis modelImmunogenicity studies of proteins forming the T4 phage head surface.Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients.Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia.Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar TyphimuriumAntibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigensSeroprevalence of Antibody-Mediated, Complement-Dependent Opsonophagocytic Activity against Neisseria meningitidis Serogroup B in England.Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal studyCorrelates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges.Genital tract interleukin-8 but not interleukin-1beta or interleukin-6 concentration is associated with bacterial vaginosis and its clearance in HIV-infected and HIV-uninfected women.Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique.Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.Maternal antibody at delivery protects neonates from early onset group B streptococcal disease.Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in MozambiquePertussis seroepidemiology in women and their infants in Sarlahi District, Nepal.Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera.Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trialEvaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides
P2860
Q28391462-1374F0D9-35B4-4EE3-8421-AE616C962384Q31145194-24B2A118-B628-43A4-8319-4F8C85F1DFEDQ33297012-5DC0C2E4-1A98-4165-A6EB-D736FD93C530Q33613509-8F411648-601A-4099-9FCD-E8C5C5F860EDQ33991967-C6DFD0CE-3D3F-4B31-AAD3-01315ADC7297Q34120926-D3718FDE-E3E6-4B16-ABB7-A77FECB0F090Q34492730-4C495668-6B66-4EFD-8830-2D23B6303D33Q34593930-BCD22C3C-57BF-4064-92F5-09F917C46BE6Q34645475-28A32C30-EF32-45A3-B70F-2939505AC8EAQ35018548-C7B2D0B3-3E37-4BFB-9C79-54F99F29A977Q35062854-AC9EB4EC-2594-486F-883B-D26D2DDF1F65Q35098175-0283A3CA-BCA0-4299-A212-BFD5005A9EE6Q35122775-83515D40-BA2A-498A-AB51-1FFB87C2AB4FQ35330733-940661AA-D11B-4682-AB6B-C6D8BE50918CQ35548013-455D069C-7CD9-4C32-86C9-B4257EB1FD32Q35782767-2120846D-9039-4F81-B623-340026E79548Q35886464-D1EF851E-06BE-48CA-B588-196476403379Q36410668-94E1804C-2B0E-4D2F-A744-DF88F453DA06Q37355917-ACC771E8-859F-4E9B-86F3-560E713616D2Q37361495-42289EBD-EBD7-480E-98A8-D65CBDDF9E7CQ37545016-8ED795BA-543B-4B36-B60A-C1278C41EA5EQ37582324-1673D235-CDA2-4AB2-A217-DCD92CA15635Q42406285-F8AA686F-C81D-4262-9917-7897219FDBD8Q43167553-57CADFE3-74AD-4C1E-8919-6A4A0747B7CEQ43233924-DF8EDE2F-79AE-468A-82DA-F3D6AE15F3CEQ57299814-2C5AEF5E-11D7-4D6C-90A3-4CB4BC14543FQ58795940-06AF863B-44D5-4BF0-9C73-77D63CFA4ABA
P2860
The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The reverse cumulative distrib ...... ory analysis of antibody data.
@ast
The reverse cumulative distrib ...... ory analysis of antibody data.
@en
type
label
The reverse cumulative distrib ...... ory analysis of antibody data.
@ast
The reverse cumulative distrib ...... ory analysis of antibody data.
@en
prefLabel
The reverse cumulative distrib ...... ory analysis of antibody data.
@ast
The reverse cumulative distrib ...... ory analysis of antibody data.
@en
P2093
P1433
P1476
The reverse cumulative distrib ...... ory analysis of antibody data.
@en
P2093
P304
P407
P433
P577
1995-09-01T00:00:00Z